SUMMARY This report summarises the current knowledge regarding the clinical utility of biochemical enzyme markers for both diagnostic and therapeutic purposes in acute leukaemia. The enzymes studied most extensively in this field are terminal deoxynucleotidyl transferase, adenosine deaminase, 5'-nucleotidase, purine nucleoside phosphorylase, and acid phosphatase, esterase, hexosaminidase isoenzymes. For each enzyme, the quantitative and qualitative characteristics in various immunologically defined subclasses of acute leukaemia are described. The quantitative evaluation of enzyme activities represents an adjunctive classification technique which should be incorporated into the multivariate analysis, the "multiple marker analysis." By qualitative characterisation pronounced heterogeneity of leukaemia subsets is uncovered. The application of 2'-deoxycoformycin, a specific inhibitor of adenosine deaminase, and the potential usefulness of two other enzymes as targets for treatment with selective agents is discussed.
In addition to traditional haematological methods such as morphology and cytochemistry (which have not become obsolete), highly specific techniques are required nowadays for the identification and sophisticated characterisation of malignant and normal haematopoietic cells. The recently acquired and tremendously expanded knowledge which has provided entirely new insights into the immunological, enzymological, cytogenetic, and functional aspects of leukaemia is due to some technical innovations.
Above all, three advances in cell technology enhanced the progress in the understanding of the biology of leukaemic cells-namely, cell analysis and sorting performed by flow cytometry, the production of monoclonal antibodies by the hybridoma technique, and the tissue culture methodology for Accepted for publication 1 October 1984 maintaining permanent leukaemia-lymphoma cell lines. '-3 The incorporation of many diverse disciplines such as morphology, cytochemistry, immunology, enzymology, chromosomal and cell kinetic studies, and others4 is needed for a careful analysis of the phenotypic profiles of leukaemic cells. The multidisciplinary approach, "multiple marker analysis,"3 has proved to be of considerable importance in leukaemia research. The fields of immunology and enzymology, especially whefi combined, seem to be particularly useful in phenotyping leukaemic cells and have provided a basis for a precisely defined, prognostically relevant and "biologically rationai"5 subclassification of acute leukaemias.
In this report we summarise our own experiences with biochemical enzyme markers in conjunction with results of other authors, including recent studies of the potential therapeutic use of such 117 118 '4 High TdT activities were found in the great majority (90-100%) of patients with T-ALL, common ALL (c-ALL), pre-B-ALL and null-ALL. 2730 TdT has usually been negative in all patients with B-ALL.3'-34 But 4(-60% of cases of AUL expressed high TdT activities.28 PURINE PATHWAY ENZYMES 5'-nucleotidase, adenosine deaminase, and purine nucleoside phosphorylase are three sequential purine salvage pathway enzymes which have a certain impact on the functioning of the immune system. '4 The inherited enzyme defects of 5'-nucleotidase, adenosine deaminase, and purine nucleoside phosphorylase are characteristic metabolic lesions causing or associated with congenital immune deficiency (Table 4) . '4 The simplified reaction sequence of this part of the purine metabolic pathway is seen in Fig. 1 .
Enzyme activity quantitation is the biochemical approach used most often for these three enzymes to identify leukaemia subtypes.3" Alterations in the enzymatic activity are reflected in pronounced decreases or increases in the specific activities of 5'-nucleotidase, adenosine deaminase, and purine nucleoside phosphorylase. The distributions of these three enzymes in subpopulations of normal thymocytes and peripheral lymphocytes have recently been described elsewhere.38- leukaemia.676 By the refined method of isoelectric focusing differences in acid phosphatase profiles PURINE NUCLEOSIDE PHOSPHORYLASE were seen in different ALL subtypes.972 IsoenPurine nucleoside phosphorylase concentrations zymatic changes served to define specific stages of were significantly lower in T-, B-and Null-ALL differentiation of the leukaemic blast cells within than in normal peripheral lymphocytes,41-42455456117ALL subtypes. The progression in differentiation whereas c-ALL cells showed activities within the along the presumed developmental axis was parallelnormal range. 4'-42 Purine nucleoside phosphorylase led by the increase in the incomplete repertoire of values were significantly raised in AML compared isoenzymes.73 None of the acid phosphatase isoenwith ALL, but not so when compared with normal zyme patterns, however allowed definite discriminaperipheral blood cells. 42 tion between these ALL subtypes; nor did they distinguish between myeloid and lymphoid lineages, in LYSOSOMAL HYDROLASES contrast to the above mentioned enzyme esterThese include the enzymes acid phosphatase and ase. 62" hexosaminidase, which are localised in lysosomes and act at an acid pH ( For ALL distinct enzyme marker phenotypes could be assigned to immunologically defined subsets (Fig. 2, Table 3 ). Distinct patterns of quantitatively measured enzyme activities were seen in T-, B-, common, null-and pre-B-ALL. T-ALL showed high values of TdT and adenosine deaminase and decreased values of 5'-nucleotidase and purine nucleoside phosphorylase, whereas hexosaminidase I was not found. B-ALL showed low purine nucleoside phosphorylase, low 5'-nucleotidase, and variable adenosine deaminase values; TdT and hexosaminidase I were negative. Pre-B-ALL showed positivity for TdT and hexosaminidase I. Common ALL and Null-ALL had a pattern of enzyme activity similar to that found in T lymphoblasts in so far as TdT and adenosine deaminase values were high; but, in contrast 5'-nucleotidase was significantly increased along with the expression of hexosaminidase I in c-ALL, whereas null-ALL had normal 5'-nucleotidase and low purine nucleoside phosphorylase values.
Qualitative ALL subset analysis of esterase, acid phosphatase, and hexosaminidase showed that the expression of isoenzymes and isoenzyme patterns may correlate with lymphocyte differentiation. This interpretation supports other studies which seem to indicate that lymphoid leukaemic differentiation is "frozen" at some specific developmental point (see below). 86 Drexler, Gaedicke, Minowada Enzyme inhibition-a new strategy in leukaemia therapy Previous approaches to the biochemical exploration of enzyme functions in leukaemic cells have focused on the value of enzymes only for diagnostic purposes. Several recent observations suggest, however, that the selective inhibition of some of these enzymes represents another intricate aspect of the use of enzymes in leukaemia.
The hereditary deficiency of adenosine deaminase (Table 4) , which is responsible for the conversion of adenine to inosine (Table 2) , results in cell toxicity via accumulation of compounds located earlier in the metabolic pathway-for example, dATP in the case of adenosine deaminase. '4 These findings served as the basis for pharmacological investigations of enzyme inhibitors in the treatment of leukaemia.
2'-deoxycoformycin is a potent and specific inhibitor of adenosine deaminase which produces by its lymphotoxicity selective lymphopenia ( Although the results of these still preliminary but promising studies suggest that these inhibitors could be both effective cytolytic agents and highly specific for some particular cells (for example, T lymphoblasts), the potential usefulness of these compounds or similar analogues in the treatment of leukaemia has yet to be further explored.
Role of enzyme markers in the concept of maturation arrest
The question arose as to whether certain isoenzymes reflect a characteristic, perhaps even specific, feature of the given leukaemic population or stem from the normal expression of cells otherwise only passing through this stage of differentiation. It seems that the leukaemic cells express these gene products (for example, the isoenzyme hexosaminidase I), which are normally found only during certain early phases of cell development, permanently because the blast cell development is blocked at this particular point. The detection of this isoenzyme hexosaminidase I would be comparable to taking one single frame out of a running film. Such theories have already been reported and emerged primarily from immunological studies comparing leukaemic cells and their supposed normal counterparts.
Evidence supporting the concepts of frozen differentiation,'03 maturation arrest,"04 and lineage fidelity"'5 is provided by the recent studies using monoclonal antibodies to identify a large panel of immunological markers.5 No unequivocally leukaemia specific antigens have been described so far,35 which further emphasises the above models. Nevertheless, as it seemed unlikely that leukaemia differentiation always mimics the normal course of development precisely and the pathological lesions underlying the leukaemic process might affect such mechanisms, after careful testing many individual cases "a possible asynchrony of gene expression '5 was noted. Likewise, the observation of highly raised activities of certain enzymes or the inappropriate occurrence of isoenzymes might be construed as a quantitative amplification of a normal process86 123 or "the abnormal, deranged expression of normal gene products. "'06 Thus "reprogramming of gene expression"'00 in leukaemic cells might be reflected in both quantitative and qualitative alterations.'00 The malignant program may be characterised by the capacity of the leukaemic cells for an escalation in expression of leukaemic properties-for example, an amplification of enzyme activity or an isoenzyme inbalance. '00 As an alternative to models of leukaemic processes that postulate that the normal differentiation programs are merely blocked stands the hypothesis that leukaemic programs are assembled abnormally-that is, programs are abnormal if an extreme deviation could be found. 86 
